Article Sidebar

Submitted
Apr 12, 2021
Published
Apr 12, 2021
Download
PDF
Statistic
Read Counter : 60 Download : 56

Main Article Content

Abstract

Background


Major population in developing countries purchases medicine through out-of-pocket payment thus making them the largest family expenditure item after food. As a result, medicines are unaffordable for large sections of the global population and a major burden on government budgets. In developing country India, price of drugs play a major role in prescribing a drug for treatment.


Methods


An analytical study was done for comparing price variations among various drugs prescribed in thromboembolic disorders. Indian Drug Review (IDR) (January 2019) and CIMS (October December 2018) was referred to know the maximum and minimum price in INR of drugs in all available strength and dosage forms being manufactured by different companies in India and percentage price variation was calculated.


Results


Wide variation in the price of several brands of same anticoagulants, fibrinolytics, antiplatelets and their combinations were found in Indian pharmaceutical market. Highest percentage price variation was found for Aspirin 150 mg + Clopidogrel 75 mg Tablet (741.03%) combination. Percentage price variation is >100% for all the different combinations of aspirin + clopidogrel. In single drug, highest percentage price variation was found for Aspirin 100 mg Tablet (435.13%) followed by Aspirin 75 mg Tablet (403.78%), Clopidogrel 75 mg Tablet (275%), Aspirin 50 mg Tablet (221.96 %). In single drug, lowest percentage price variation was found for Eftifibatide 20mg/10 ml injection (1.15%) followed by Tirofiban 5mg/100 ml injection (2.63%), Warfarin 5 mg Tablet (3.23%).


Conclusion


Steps should be taken by the government towards reduction in price variation among the various brands so as to them affordable and aim to improve the health status of community. This will definitely reduce the economic burden on government. The purpose of “Health for all” can only be achieved by efforts from all stakeholders.

Keywords

Price variation Thromboembolic disorders Indian pharmaceutical market

Article Details

How to Cite
Neeta J. Kanani, & Vimesh R. Mistry. (2021). Price variation analysis of various drugs used for thromboembolic disorders currently available in Indian pharmaceutical market. International Journal of Research in Pharmacology & Pharmacotherapeutics, 8(2), 294-301. https://doi.org/10.61096/ijrpp.v8.iss2.2019.294-301
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis. Lancet. 373, 2009, 240–9.
  2. [2]. Shrank WH, Hoang T, Ettner SL. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 166(3), 2006, 332-7.
  3. [3]. Morbidity, Health Care and the Condition of the Aged NSS 60th round National Sample Survey Organization Ministry of Statistics and Programme Implementation 2004.
  4. [4]. Drugs affecting coagulation, fibrinolysis and platelet function. Sharma HL, Sharma KK. Principles of Pharmacology. New Delhi, India: Paras Publications; 3, 2017, 681-99.
  5. [5]. Gupta R, Mohan I, Narula J. Trends in Coronary Heart Disease Epidemiology in India. Ann Glob Health. 82(2), 2016, 307-15.
  6. [6]. Das SC, Mandal M, Mandal SC. A critical study on availability and price variation between different brands: Impact on access to medicines. Ind J Pharm Sci 69, 2007, 160-3.
  7. [7]. Deepak KR, Geetha A. Price variation analysis of various brands of anticoagulants, fibrinolytics, and antiplatelet drugs currently available in Indian pharmaceutical market. Natl J Physiol Pharm Pharmacol 9(5), 2019, 368-372.
  8. [8]. Jadhav NB, Bhosale MS, Adhav CV. Price analysis study of oral antidiabetic drugs available in indian market. Int J Med Res Health Sci. 2(1), 2013, 63-69.
  9. [9]. Kumar R, Manu C, Singh DJ, Lakhani P, Tutu S, Dixit R. The extent of price variation amongst branded antihypertensive drugs and its association with number of pharmaceutical companies. Int J Res Med Sci 3, 2015, 2800-6.
  10. [10]. Chawan VS, Badwane SV, Gawand KV, Chhaya MU. Analysis of price variation amongst different formulations of anxiolytic drugs available in Indian market. Int J Res Med Sci 4, 2016, 2398-401.
  11. [11]. Mamatha KR, Vishnu K. Price variation analysis of various brands of oral hypolipidemic drugs available in Indian pharmaceutical market. Int J of Res in Pharmacology & Pharmacotherapeutics 6(3), 2017, 381-8.
  12. [12]. Patel BS, Chavda FM and Mundhava SG: Price Variation Analysis of Single Nonsteroidal Anti-Inflammatory Agents Available In Indian Market: An Economic Perspective. Int J Pharm Sci Res 7(5), 2016, 2174-80
  13. [13]. Maiti R, Bhatia V, Padhy BM, Hota D. Essential medicines: An Indian perspective. Indian J Community Med 40, 2015, 223-32
  14. [14]. Mathew P. Generic drugs: Review and experiences from South India. J Family Med Prim Care. 4(3), 2015, 319–323.
  15. [15]. Mulakaluri PP; Generic medicines in the Indian scenario – What are we expecting? Telangana Journal of Psychiatry, 3(1), 2017, 1-3
  16. [16]. Narula S Current Drug Pricing Status in India. Pharmacoeconomics 1, 2015, e101
  17. [17]. Drug Price Control Order [Online]. 2013 Available from: URL: http://www.nppaindia.nic.in/ DPCO2013.pdf Accessed 15, 2019.
  18. [18]. Frazier LM, Brown JJ, Divine GW. Can physician education lower the price of prescription drugs? A prospective Controlled trial. Annals of Internal Medicine. 115, 1991, 116-21.
  19. [19]. Jana S, Mondal P. Pharmacoeconomics: The need to sensitize undergraduate medical students. Indian Journal of Pharmacology. 37(5), 2005, 277-278.